Irritable bowel syndrome: Diagnosis is based on clinical criteria

Postgraduate Medicine

Volumn 112, Issue 5, 2002, Pages 30-41

  Morgan, Torre ^a   Robson, Kristen M ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; COLESTYRAMINE; DESIPRAMINE; DICYCLOVERINE; HYOSCYAMINE; LAXATIVE; LOCHOLEST; LOPERAMIDE; MAGNESIUM CITRATE; NOPRAMIN; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SORBITOL; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ALTERNATIVE MEDICINE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DIARRHEA; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DRY EYE; HUMAN; INFECTION; INTESTINE MOTILITY; IRRITABLE COLON; META ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOSOCIAL DISORDER; SENNA; SIDE EFFECT; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

EID: 0036845723     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2002.11.1343     Document Type: Conference Paper

References (35)

1. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2(6138):653-4
2. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Ann Intern Med 2000;133(2):136-47
3. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100(4):998-1005
4. Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99(2):409-15
5. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38(9):1569-80
6. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112(6):2120-37
7. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109(6):1736-41
8. Cann PA, Read NW, Brown C, et al. Irritable bowel syndrome: Relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983;24(5):405-11
9. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92(6):1885-93
10. Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med 2001;344(24):1846-50
11. Rothstein RD. Irritable bowel syndrome. Med Clin North Am 2000;84(5):1247-57
12. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98(5 Pt 1):1187-92
13. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000;118(5):842-8
14. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ 1997;314(7083):779-82
15. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44(3):400-6
16. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95(12):3503-6
17. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95(3):701-8
18. Whitehead WE, Bosmajian L, Zonderman AB, et al. Symptoms of psychologic distress associated with irritable bowel syndrome: Comparison of community and medical clinic samples. Gastroenterology 1988;95(3):709-14
19. Drossman DA, Talley NJ, Leserman J, et al. Sexual and physical abuse and gastrointestinal illness: Review and recommendations. Ann Intern Med 1995;123(10):782-94
20. Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med 1993; 329(26):1940-5
21. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med 1999;107(5A):5-11S
22. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Supp 2):1143-7
23. Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999;107(5A):20-65
24. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122(2):107-12
25. Drossman DA, Thompson WG. The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116(12 Pt 1):1009-16
26. Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 1999;107(5A):27-32S
27. Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15(3):355-61
28. Gorard DA, Libby GW, Farthing MJ. Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndrome. Dig Dis Sci 1995;40(1):86-95
29. Clouse RE. Psychotropic medications for the treatment of functional gastrointestinal disorders. Clin Perspect Gastroenterol 1999;2(Nov/Dec):348-56
30. Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet 2000;355(9209):1035-40
31. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000;118(3):463-8
32. Zelnorm Package Insert. East Hanover, NJ: Novartis Pharmaceuticals, July 2002
33. Cann PA, Read NW, Holdsworth CD, et al. Role of loperamide and placebo in management of irritable bowel syndrome (1BS). Dig Dis Sci 1984; 29(3):239-47
34. Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45(Suppl 2):1125-30
35. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: A critical review and meta-anlysis. Am J Gastroenterol 1998;93(7):1131-5